Food and Drug Administration Approvals

June 2003 The novel multiple myeloma agent Velcade (bortezomib) gets fast FDA approval.
June 13, 2003
May 2003 The FDA approves 2 new enzyme replacement products, Aldurazyme (laronidase) and Fabrazyme (agalsidase beta).
May 28, 2003
Food and Drug Administration Approvals, April 2003 FDA approves novel agents--Fuzeon (enfuvirtide), Emend (aprepitant), and Somavert (pegvisomant).
April 23, 2003
Food and Drug Administration Approvals, March 2003 Read an update on recent FDA approvals, including Effexor XR (venlafaxine) approved for the treatment of social anxiety disorder, and pyridostigmine for exposure to nerve gas.
March 20, 2003
Food and Drug Administration Approvals, February 2003 Novel product approvals slow down and the FDA responds with a new course for change.
February 20, 2003
Food and Drug Administration Approvals, January 2003 Biologics gain new approval with adalimumab, a novel monoclonal antibody for rheumatoid arthritis.
January 16, 2003
Food and Drug Administration Approvals, December 2002 New therapies for attention deficit/hyperactivity disorder, osteoporosis, and schizophrenia were recently approved by the FDA.
December 30, 2002
Food and Drug Administration Approvals - November 2002 This month's column reviews FDA approvals for a second pegylated interferon for hepatitis C, plus new treatments for hypercholesterolemia, diabetes, and more.
November 19, 2002
October 2002 Read about the new drug approval for Hepsera for chronic hepatitis B and other recent FDA approvals and labeling changes.
October 23, 2002
September 2002 The first in a series of monthly columns discussing recent Food and Drug Administration approvals.
September 01, 2002